Literature DB >> 15636633

Sirolimus impairs improvement of the gonadal function after renal transplantation.

Vincenzo Tondolo, Franco Citterio, Nicola Panocchia, Giuseppe Nanni, Marco Castagneto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15636633     DOI: 10.1111/j.1600-6143.2005.00604.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  6 in total

1.  The effect of sirolimus on prostate-specific antigen (PSA) levels in male renal transplant recipients without prostate cancer.

Authors:  K Chamie; P M Ghosh; T M Koppie; V Romero; C Troppmann; R W deVere White
Journal:  Am J Transplant       Date:  2008-10-06       Impact factor: 8.086

Review 2.  Management of pregnancy in the post-cardiac transplant patient.

Authors:  Marwah Abdalla; Donna M Mancini
Journal:  Semin Perinatol       Date:  2014-06-25       Impact factor: 3.300

Review 3.  Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide.

Authors:  Mark Davies; Anurag Saxena; John C Kingswood
Journal:  Orphanet J Rare Dis       Date:  2017-02-15       Impact factor: 4.123

Review 4.  Hormonal (Im)Balance and Reproductive System's Disorders in Transplant Recipients-A Review.

Authors:  Dagmara Szypulska-Koziarska; Kamila Misiakiewicz-Has; Barbara Wiszniewska
Journal:  Biology (Basel)       Date:  2021-03-26

Review 5.  Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease.

Authors:  Katarzyna Romejko; Aleksandra Rymarz; Hanna Sadownik; Stanisław Niemczyk
Journal:  Nutrients       Date:  2022-08-21       Impact factor: 6.706

Review 6.  Immunosuppressive drugs and fertility.

Authors:  Clara Leroy; Jean-Marc Rigot; Maryse Leroy; Christine Decanter; Kristell Le Mapihan; Anne-Sophie Parent; Anne-Claire Le Guillou; Ibrahim Yakoub-Agha; Sébastien Dharancy; Christian Noel; Marie-Christine Vantyghem
Journal:  Orphanet J Rare Dis       Date:  2015-10-21       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.